Literature DB >> 9453378

Hyporeactivity of neonatal platelets is not caused by preactivation during birth.

B Grosshaupt1, W Muntean, P Sedlmayr.   

Abstract

UNLABELLED: Little information exists concerning platelet function in neonates due to the small blood volume. Most studies using conventional aggregation methods have shown a diminished response to various agonists. This is in contrast to the lack of a bleeding tendency and to a short bleeding time in healthy neonates. In previous work we have shown that in healthy term neonates even after an uncomplicated delivery signs of thrombin generation can be demonstrated. This activation of the clotting system may also lead to platelet activation in the neonate. We investigated by means of flow cytometry the expression of activation markers GMP 140 and GP 53 on the surface of neonatal platelets and GP 53 intracellularly by means of a newly developed assay. The expression of GMP 140 and of GP 53 after thrombin stimulation was significantly higher on adult rather than neonatal platelets, while there was no difference between neonatal and adult platelets using GP 53 as intracellular marker. In none of the healthy term neonates after an uncomplicated delivery were activated platelets demonstrated.
CONCLUSION: Our data show that the decreased reactivity of neonatal platelets is not caused by preactivation during birth but rather represents a developmental phenomenon. Possibly the observed hyporeactivity of neonatal platelets to thrombin helps to prevent harmful effects of birth stress on the clotting system of neonates.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9453378     DOI: 10.1007/s004310050748

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  8 in total

Review 1.  The neonatal coagulation system and the vitamin K deficiency bleeding - a mini review.

Authors:  Ewald Pichler; Ludwig Pichler
Journal:  Wien Med Wochenschr       Date:  2008

2.  Deposition of whole blood platelets on extracellular matrix under flow conditions in preterm infants.

Authors:  N Linder; B Shenkman; E Levin; L Sirota; T H Vishne; I Tamarin; R Dardik; D Lubin; N Savion; D Varon
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-03       Impact factor: 5.747

3.  Neonatal thrombocytopenia: Thrombin generation in presence of reduced platelet counts and effects of rFVIIa in cord blood.

Authors:  Harald Haidl; Sina Pohl; Bettina Leschnik; Siegfried Gallistl; Wolfgang Muntean; Axel Schlagenhauf
Journal:  Sci Rep       Date:  2019-05-29       Impact factor: 4.379

Review 4.  Platelets in pediatric and neonatal sepsis: novel mediators of the inflammatory cascade.

Authors:  Daniel O'Reilly; Claire A Murphy; Richard Drew; Afif El-Khuffash; Patricia B Maguire; Fionnuala Ni Ainle; Naomi Mc Callion
Journal:  Pediatr Res       Date:  2021-10-28       Impact factor: 3.756

5.  Neonatal Platelets: Lower G12/13 Expression Contributes to Reduced Secretion of Dense Granules.

Authors:  Axel Schlagenhauf; Sheila Bohler; Mirjam Kunze; Tanja Strini; Harald Haidl; Miriam Erlacher; Barbara Zieger
Journal:  Cells       Date:  2022-08-17       Impact factor: 7.666

Review 6.  Inflammatory responses in hypoxic ischemic encephalopathy.

Authors:  Fudong Liu; Louise D McCullough
Journal:  Acta Pharmacol Sin       Date:  2013-07-29       Impact factor: 6.150

7.  Polyphosphate in Neonates: Less Shedding from Platelets and Divergent Prothrombotic Capacity Due to Lower TFPI Levels.

Authors:  Axel Schlagenhauf; Harald Haidl; Sina Pohl; Eva-Christine Weiss; Bettina Leschnik; Siegfried Gallistl; Wolfgang Muntean
Journal:  Front Physiol       Date:  2017-08-24       Impact factor: 4.566

Review 8.  The role of the calibrated automated thrombogram in neonates: describing mechanisms of neonatal haemostasis and evaluating haemostatic drugs.

Authors:  Claire A Murphy; Elaine Neary; Daniel P O'Reilly; Sarah Cullivan; Afif El-Khuffash; Fionnuala NíAinle; Patricia B Maguire; Naomi McCallion; Barry Kevane
Journal:  Eur J Pediatr       Date:  2021-07-20       Impact factor: 3.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.